课题基金基金详情
金属蛋白酶ADAMTS-13对von Willebrand factor还原作用的机制研究
结题报告
批准号:
81300222
项目类别:
青年科学基金项目
资助金额:
23.0 万元
负责人:
周洲
学科分类:
H0214.动脉粥样硬化与动脉硬化
结题年份:
2016
批准年份:
2013
项目状态:
已结题
项目参与者:
张洋、欧阳文斌、张银辉、王宪云、马凯
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
冠状动脉心脏病(冠心病)是导致人类死亡的首要因素。在血管中形成的血栓如果堵塞冠状动脉,将造成心肌梗死的发生。血浆中的von Willebrand factor (VWF) 多聚体可聚集活化血小板,在血栓形成过程中至关重要。血浆中金属蛋白酶ADAMTS-13通过剪切VWF多聚体,调节机体凝血与血栓系统的功能。在高速流体剪切力作用下,正常VWF多聚体通过表面游离巯基重组形成新的二硫键,其活性部位暴露后与血小板主动结合形成血小板血栓,导致高活性的VWF多聚体的消耗,从而使患者的出血倾向增高。本课题组进一步证实,ADAMTS-13阻止流体剪切力导致的VWF二硫键置换,其还原活性是通过非蛋白酶结构域内的活性游离巯基起作用。本申请将研究对ADAMTS-13还原活性起关键作用的活性游离巯基,以及流体剪切力对此调节功能的影响。同时检测冠心病患者中VWF多聚体二硫键分布的变化,探讨其与疾病发生发展的关联。
英文摘要
Coronary artery disease (CAD) is the leading cause of death around the world. The thrombi formed within the vessels block the blood flow of coronary arteries, which lead to myocardial infarction. von Willebrand factor (VWF) multimers are critical for thrombus formation through recruiting and aggregating platelets in plasma. The size and function of VWF multimers can be regulated by the metalloprotease ADAMTS-13 to maintain the normal hemostasis in the body. Normal VWF multimers circulating in plasma do not bind platelets, whereas they are activated by the high shear stress to bind and aggregate platelet spontaneously, resulting in the bleeding tendency because of the consumption. The previous studies have shown that plasma VWF multimers were induced by the shear stress to form the disulfide bonds through surface-exposed free thiols. Recently, there were several reports that the reductants can regulate the size and function of VWF multimers by reducing the disulfide bonds and the effects are reversible. Our study has further demonstrated that ADAMTS-13 contains a disulfide bond reducing activity that primarily targets disulfide bonds in plasma VWF multimers induced by high shear stress. Interestingly, ADAMTS-13 acts as a reductase by using the cysteine thiols in its non-proteolytic regions that remain exposed after being subjected to hydrodynamic forces. Blocking these active thiols eliminates the reducing activity and moderately decreases ADAMTS-13 activity in cleaving ULVWF strings under flow conditions. The present study will further investigate which cysteine thiols in ADAMTS-13 play key roles to reduce VWF multimers and how shear stress affects the process. Since VWF multimers are important in developing the CAD lesions, we will measure the thiol/disulfide pattern of VWF multimers in the plasma of CAD patients and associate with the severity of the disease.
冠状动脉心脏病(冠心病)是导致人类死亡的首要因素。在血管中形成的血栓如果堵塞冠状动脉,将造成心肌梗死的发生。血浆中的von Willebrand factor (VWF) 多聚体可聚集活化血小板,在血栓形成过程中至关重要。血浆中金属蛋白酶ADAMTS-13通过剪切VWF多聚体,调节机体凝血与血栓系统的功能。在高速流体剪切力作用下,正常VWF多聚体通过表面游离巯基重组形成新的二硫键,其活性部位暴露后与血小板主动结合形成血小板血栓,导致高活性的VWF多聚体的消耗,从而使患者的出血倾向增高。本课题组进一步证实,ADAMTS-13阻止流体剪切力导致的VWF二硫键置换,其还原活性是通过非蛋白酶结构域内的活性游离巯基起作用。本申请将研究对ADAMTS-13还原活性起关键作用的活性游离巯基,以及流体剪切力对此调节功能的影响。同时检测冠心病患者中VWF多聚体二硫键分布的变化,探讨其与疾病发生发展的关联。.本研究对患者年龄、性别与炎性状态、血凝、以及血脂指标的相关性进行分析;探究对ADAMTS-13还原活性起关键作用的活性游离巯基,以及流体剪切力对此调节功能的影响;利用VWF瑞斯托霉素辅因子活性检测(vWF:Rcof)的方法分别对冠心病患者血浆(175例)和瓣膜病患者的血浆(180例)进行了VWF的抗原检测,结果显示,在冠心病患者中的VWF水平明显高于瓣膜病患者。
专著列表
科研奖励列表
会议论文列表
专利列表
利用单细胞转录组研究视黄酸信号在大动脉转位发生、发展中的作用机制
利用单细胞测序技术研究脂肪间充质干细胞向血管平滑肌细胞定向分化的机制
金属蛋白酶ADAMTS13表达调控的机制研究
国内基金
海外基金